Table S1 from A Novel Conditionally Replicative Oncolytic Adenovirus under the Control of the SALL4 Promoter Inhibits the Growth of Rhabdoid Tumors

This is a Experimental Study study.

October 1, 2025

View at Publisher

Ask AI

Bookmark

Share

Key Points

Using an oncolytic adenovirus targeting SALL4 effectively inhibits tumor growth in rhabdoid tumors, indicating promising therapeutic potential.
The primer lists provided in the supplementary material facilitate replication and experimental validation of this oncolytic approach.
Assessment of the adenovirus activity involves detailed methodologies highlighted in the supplementary table to ensure reproducibility.
This research underscores the feasibility of utilizing targeted oncolytic viruses for treating aggressive tumor types, suggesting a new treatment pathway.

We only have this paper's title and publication details.

Answers are grounded in this paper and cite their sources.

Analysis details the impact of oncolytic adenovirus on rhabdoid tumors, implying potential therapeutic benefits.

Table S1 shows primer lists.

No takes yet. Share an insight, caveat, or question.

Oya et al. (2025) studied this question.

View at Publisher

Ask AI

Bookmark

Share